Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
DUBLIN, IRELAND/BEDMINSTER, US: Shire plc and NPS Pharmaceuticals, Inc announced that the companies have entered into a merger agreement pursuant to which Shire will acquire all the outstanding shares of NPS Pharma for $46.00 per share in cash, for a total consideration of approximately $5.2 billion. Shire will accelerate the growth of NPS Pharma’s innovative portfolio through its market expertise in gastrointestinal (GI) disorders, core capabilities in rare disease patient management, and global footprint. The transaction has been approved unanimously by the Boards of Directors of both Shire and NPS Pharma. The $46.00 per share price in the transaction represents a 51 per cent premium to NPS Pharma’s unaffected share price of $30.47 on 16 December 2014.
“The acquisition of NPS Pharma is a significant step in advancing Shire’s strategy to become a leading biotechnology company. With our global strength and expertise in both rare diseases and GI, Shire is uniquely positioned to drive the continued success of GATTEX/REVESTIVE, and, if approved, commercialize NPS Pharma’s pipeline compound NATPARA/NATPAR. We look forward to accelerating the growth of the NPS Pharma portfolio based on our proven track record of maximizing value from acquired assets and commercial execution. The NPS Pharma organization will be a welcome addition to Shire as we continue to help transform the lives of patients with rare diseases,” said Flemming Ornskov, Chief Executive Officer, Shire.
© Worldofchemicals News
Login
CALIFORNIA, US: University of California, Santa Barbara’s (UCSB) Reich Group uses lasers to spatially and temporally control the release of a ta ...
ALBANY, US: Albany Molecular Research Inc (AMRI) has acquired the outstanding equity interests of Aptuit’s Glasgow, UK business and has entered ...
TOKYO, JAPAN: Nippon Shokubai Co Ltd announced that at the end of 2014 it ceased manufacturing at its Suita Plant in the city of Suita, Japan, a produ ...
RICHMOND, US: MeadWestvaco Corporation (MWV), a global leader in packaging and packaging solutions, has approved a plan to fully separate its Specialt ...
BANGKOK, THAILAND: Indorama Ventures PCL (IVL), one of the world’s foremost petrochemical producers, has reached a definitive agreement with Pol ...
LONDON, UK: In a massive breakthrough, scientists have created the first new antibiotic in more than three decades, Teixobactin, that can treat many c ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder